Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer

BACKGROUND: Therapeutic interventions in the insulin-like growth factor receptor (IGF-1R) pathway were expected to provide clinical benefits; however, IGF-1R tyrosine kinase inhibitors (TKIs) have shown limited antitumor efficacy, and the mechanisms conveying resistance to these agents remain elusiv...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mol Cancer
Main Authors: Min, Hye-Young, Yun, Hye Jeong, Lee, Ji-Sun, Lee, Hyo-Jong, Cho, Jaebeom, Jang, Hyun-Ji, Park, Shin-Hyung, Liu, Diane, Oh, Seung-Hyun, Lee, J. Jack, Wistuba, Ignacio I., Lee, Ho-Young
格式: Artigo
語言:Inglês
出版: BioMed Central 2015
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453276/
https://ncbi.nlm.nih.gov/pubmed/26041671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-015-0392-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍